We read with great interest the article by Fasen et al,1 which addresses an important and often underappreciated topic in radiology: diagnostic errors and, more specifically, missed large- and medium-vessel occlusions on CT angiography in patients with acute ischemic stroke. Little is known about the factors that lead to such errors, and the article adds important knowledge in this regard. Fasen et al found that a more distal occlusion location in the M2 segment in the middle cerebral artery (ie, medium-vessel occlusions [MeVOs]2) was missed in 82% of cases at the time of the initial CTA evaluation, and M2 occlusion location was significantly associated with the initial missing of the occlusion. M2 occlusions are increasingly targeted with endovascular thrombectomy (EVT),3 and it is, thus, crucial to accurately and reliably detect them. Fasen et al relied on axial single-phase CTA images to detect M2 occlusion, which is often challenging because the M2 segment is small in caliber and does not run horizontal to the axial plane.
Multiphase CTA (mCTA), which comprises 2 delayed phases in addition to the arterial phase with no additional contrast and minimal additional time and radiation dose,4 was successfully used for large-vessel occlusion (LVO) detection and EVT patient selection in the Endovascular Treatment for Small Core and Proximal Occlusion Ischemic Stroke (ESCAPE) and Safety and Efficacy of NA-1 in Subjects Undergoing Endovascular Thrombectomy for Stroke (ESCAPE-NA1) trials5,6 and MeVOs are much easier to catch on mCTA because a contrast hold-up is often seen in the downstream territory (Figure A–C). Recent advances in mCTA postprocessing have rendered real-time generation of color-coded mCTA maps possible, which facilitates detection of LVOs and particularly MeVOs even further (Figure E).7 Lastly, mCTA can also be used to generate tissue-level perfusion maps just as CT perfusion does. In these maps, striking color changes in the downstream territory allow quick and easy detection of MeVOs (Figure F). We are convinced that the number of missed M2s would have been much lower had mCTA rather than single-phase CTA been used in the study of Fasen et al,1 and we encourage the use of mCTA in the acute stroke setting to minimize the risk of missing potential EVT target occlusions, which dramatically impacts patient management and, ultimately, worsens patient outcomes.
Footnotes
Disclosures: Johanna M. Ospel—UNRELATED: Grants/Grants Pending: Julia Bangerter Rhyner-Stiftung Foundation, University of Basel Research Foundation, Freiwiliige Akademische Gesellschaft Basel, Comments: research scholarships. Wu Qiu—UNRELATED: Employment: University of Calgary. Mayank Goyal—RELATED: Grant: Stryker, Cerenovus*; Consulting Fee or Honorarium: Medtronic, Stryker, MicroVention, Mentice; Other: GE Healthcare, Comments: licensing agreement, systems of acute stroke diagnosis. *Money paid to the institution.
References
- © 2020 by American Journal of Neuroradiology